Supplement Clinical Trial
Official title:
A Randomized, Double Blind, Crossover Study to Compare the Tolerability of Microencapsulated Iron Compared to a Conventional Iron Supplement in the Market
The purpose of this study is to compare the frequency of appearance of the total clinical manifestations (expected adverse event: nausea, vomiting, heartburn, abdominal pain, gas/swelling, diarrhea, headache, shortness of breath, metallic taste and constipation) after consuming microencapsulated iron and comparator for 14 days.
Subjects will consume a daily dose once per day for 14 days with a washout period of two menstrual cycles between the two products. After this washout period, subjects will return to the clinical and will undergo identical procedures with counter order of the intervention. Each day of the study will be recorded in a diary by each subject. Participants will be requested not to change their regular life habits and diet during the entire study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04065061 -
Erinacine A-enriched Hericium Erinaceus Mycelia for Improvement of Recognition, Vision, and Functional MRI Alterations
|
N/A | |
| Completed |
NCT05304299 -
Alleviating Effects Against High Intraocular Pressure by Oral Intake of Cordyceps Cicadae Mycelia
|
N/A | |
| Completed |
NCT01971723 -
Multi-ingredient Supplement for Strength and Power
|
N/A | |
| Completed |
NCT03769012 -
Ability of Beta-glucan Supplementation to Augment Immune Function
|
N/A | |
| Completed |
NCT04063735 -
Alleviating Effects Against Dry Eye by Oral Intake of Cordyceps Cicadae Mycelia
|
N/A |